#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Infantile apnoea Stargardt's disease Acute myeloid leukaemia (in remission) Keratosis follicular Ewing's sarcoma Renal transplant Myelodysplastic syndrome with excess blasts Pustular psoriasis Acquired ATTR amyloidosis B-cell type acute leukaemia Leukocyte adhesion deficiency Malformation venous SAPHO syndrome Palmoplantar pustulosis Dementia More trials…

    Learn about Rare Diseases

    Retinoblastoma – Trials in Disease Soft tissue sarcoma Mitochondrial myopathy Hereditary angioedema X-linked lymphoproliferative syndrome – Treatment Usher’s syndrome – Trials in Disease Wiskott-Aldrich syndrome Ocular melanoma – Treatment Mantle cell lymphoma refractory – Trials in Disease Adrenocortical carcinoma – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Rosuvastatin Calcium Cetrorelix Fluoroethyltyrosine F-18 Terbinafine Hydrochloride Tilsotolimod Sodium Ads-013 AZD5335 Zasocitinib Mva-209-Fsp-B4 Calcipotriol Fosphenytoin Sodium Rilvegostomig VIPOGLANSTAT OBI-821 Glutathione Etelcalcetide Wt1/Il15/Il15Ra Mrna Dc Human Serum Albumin PICLIDENOSON Mirvetuximab Soravtansine More therapies…

    Learn about Your Condition

    BK virus infection Heparin resistance Cardiac failure chronic Hepatic fibrosis Anxiety Meniscus operation Cholestatic pruritus Renal injury Diabetic ketoacidosis Invasive breast carcinoma Tourette's disorder Breast cancer stage IV Labour induction Systemic candida Atrial fibrillation More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Hopitaux Universitaires Pitie Salpetriere

Hopitaux Universitaires Pitie Salpetriere

47 Boulevard De L Hopital, Paris, 75651, France

Want to learn more about this study or check if you can participate? Contact us.

  • Study on Glioblastoma Treatment with Metformin, Temozolomide, and Radiotherapy for Newly Diagnosed Patients

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Glioblastoma
    • Glioblastoma multiforme
    Investigated Drugs:
    • Metformin Hydrochloride
    • Temozolomide
    France

  • Study on the Safety and Effectiveness of ART0380 Alone or with Gemcitabine or Irinotecan for Patients with Advanced or Metastatic Solid Tumors

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Neoplasm
    Investigated Drugs:
    • Art0380 Mesilate
    • Irinotecan Hydrochloride
    • Gemcitabine Hydrochloride
    France Spain

  • A Phase 3 Study of Efimosfermin Alfa to Assess Safety and Tolerability in Adults with F2‑F3 Stage Metabolic Dysfunction‑Associated Steatohepatitis (MASH)

    Recruiting

    3 1
    Investigated Diseases:
    • Metabolic dysfunction-associated steatohepatitis
    Austria Belgium Bulgaria France Germany Greece +4

  • Safety and Efficacy of Efimosfermin Alfa in Participants with Biopsy‑Confirmed F2‑ or F3‑Stage Metabolic Dysfunction‑Associated Steatohepatitis (MASH)

    Recruiting

    3 1
    Austria Belgium Bulgaria France Germany Greece +4

  • Long‑Term Safety and Efficacy Study of Danicamtiv in Adults with Symptomatic Genetic and Familial Dilated Cardiomyopathy

    Not yet recruiting

    3 1 1
    Investigated Drugs:
    • Danicamtiv
    Belgium Denmark France Hungary Italy The Netherlands +3

  • Fludarabine with drug combination for older or frail patients with acute myeloid leukemia undergoing haploidentical stem cell transplant

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Acute myeloid leukaemia
    Investigated Drugs:
    • Ciclosporin
    • Cyclophosphamide
    • Fludarabine Phosphate
    France

  • Rituximab versus azathioprine for remission maintenance in patients with primary angiitis of the central nervous system – randomized controlled trial

    Not yet recruiting

    2 1 1 1
    Investigated Drugs:
    • Azathioprine
    • Rituximab
    France

  • Phase 2/3 study of telisotuzumab adizutecan with drug combination versus standard care in adults with first‑line metastatic pancreatic ductal adenocarcinoma

    Not yet recruiting

    4 1 1 1
    Investigated Diseases:
    • Pancreatic carcinoma
    Investigated Drugs:
    • Irinotecan Hydrochloride
    • Calcium Folinate
    • Fluorouracil
    Austria France Germany Italy Portugal Spain

  • Patient‑chosen treatment vs routine surgery for adult uncomplicated acute appendicitis: trial of amoxicillin‑clavulanic acid versus appendectomy

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Appendicitis
    Investigated Drugs:
    • Amoxicillin Sodium
    • Clavulanic Acid
    France

  • Evaluating venetoclax with drug combination in relapsed/refractory T‑cell acute lymphoblastic leukemia patients

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • T-cell type acute leukaemia
    Investigated Drugs:
    • Tofacitinib
    • Azacitidine
    • Everolimus
    Czechia France Germany The Netherlands Spain
Previous Page
1 … 6 7 8 9 10 … 20
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!